Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.
Shen X, Tang H, McDanal C, Wagh K, Fischer W, Theiler J, Yoon H, Li D, Haynes BF, Sanders KO, Gnanakaran S, Hengartner N, Pajon R, Smith G, Glenn GM, Korber B, Montefiori DC. Shen X, et al. Among authors: hengartner n. Cell Host Microbe. 2021 Apr 14;29(4):529-539.e3. doi: 10.1016/j.chom.2021.03.002. Epub 2021 Mar 5. Cell Host Microbe. 2021. PMID: 33705729 Free PMC article.
Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.
Hraber P, Korber BT, Lapedes AS, Bailer RT, Seaman MS, Gao H, Greene KM, McCutchan F, Williamson C, Kim JH, Tovanabutra S, Hahn BH, Swanstrom R, Thomson MM, Gao F, Harris L, Giorgi E, Hengartner N, Bhattacharya T, Mascola JR, Montefiori DC. Hraber P, et al. Among authors: hengartner n. J Virol. 2014 Nov;88(21):12623-43. doi: 10.1128/JVI.01705-14. Epub 2014 Aug 20. J Virol. 2014. PMID: 25142591 Free PMC article.
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, de Silva TI; Sheffield COVID-19 Genomics Group; McDanal C, Perez LG, Tang H, Moon-Walker A, Whelan SP, LaBranche CC, Saphire EO, Montefiori DC. Korber B, et al. Among authors: hengartner n. Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3. Cell. 2020. PMID: 32697968 Free PMC article.
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
Weissman D, Alameh MG, de Silva T, Collini P, Hornsby H, Brown R, LaBranche CC, Edwards RJ, Sutherland L, Santra S, Mansouri K, Gobeil S, McDanal C, Pardi N, Hengartner N, Lin PJC, Tam Y, Shaw PA, Lewis MG, Boesler C, Şahin U, Acharya P, Haynes BF, Korber B, Montefiori DC. Weissman D, et al. Among authors: hengartner n. Cell Host Microbe. 2021 Jan 13;29(1):23-31.e4. doi: 10.1016/j.chom.2020.11.012. Epub 2020 Dec 1. Cell Host Microbe. 2021. PMID: 33306985 Free PMC article. Clinical Trial.
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines.
Shen X, Tang H, McDanal C, Wagh K, Fischer W, Theiler J, Yoon H, Li D, Haynes BF, Sanders KO, Gnanakaran S, Hengartner N, Pajon R, Smith G, Dubovsky F, Glenn GM, Korber B, Montefiori DC. Shen X, et al. Among authors: hengartner n. bioRxiv [Preprint]. 2021 Jan 29:2021.01.27.428516. doi: 10.1101/2021.01.27.428516. bioRxiv. 2021. PMID: 33532764 Free PMC article. Updated. Preprint.
Estimating the strength of selection for new SARS-CoV-2 variants.
Dorp CHV, Goldberg EE, Hengartner N, Ke R, Romero-Severson EO. Dorp CHV, et al. Among authors: hengartner n. Nat Commun. 2021 Dec 14;12(1):7239. doi: 10.1038/s41467-021-27369-3. Nat Commun. 2021. PMID: 34907182 Free PMC article.
Estimating the strength of selection for new SARS-CoV-2 variants.
van Dorp CH, Goldberg EE, Hengartner N, Ke R, Romero-Severson EO. van Dorp CH, et al. Among authors: hengartner n. medRxiv [Preprint]. 2021 Sep 24:2021.03.29.21254233. doi: 10.1101/2021.03.29.21254233. medRxiv. 2021. PMID: 33821289 Free PMC article. Updated. Preprint.
Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron.
van Dorp C, Goldberg E, Ke R, Hengartner N, Romero-Severson E. van Dorp C, et al. Among authors: hengartner n. medRxiv [Preprint]. 2022 Jun 16:2022.06.15.22276436. doi: 10.1101/2022.06.15.22276436. medRxiv. 2022. PMID: 35734094 Free PMC article. Updated. Preprint.
71 results